SOX2 and cancer: Moreover, we found that AKT-SOX2 axis is a modulator of cancer stemness and chemoresistance and developed a combination strategy using an AKT inhibitor to decrease SOX2 protein level and enhance OS sensitivity to chemotherapeutic drugs.